Fluxion ERASE-Seq NGS Liquid Biopsy Analysis Service
Fluxion Biosciences said that its ERASE-Seq bioinformatics solution can now be used for variant calling from a wide range of targeted cancer panels. The analysis tool was previously limited to use on Fluxion's Spotlight 59 cancer panel. Users can now apply ERASE-Seq to Swift Biosciences' Accel Amplicon 56G panel and Illumina's TruSight Tumor 15 panel using bioinformatic analyses that are already cloud accessible. Other custom and commercial panels that customers may be interested in can also be added following validation testing by Fluxion, the company said.